Thumbnail

Orphan Drug 2022 Report 英語版

Treatments for orphan indications and rare diseases are no longer a niche area of focus for developers. Orphan products have become one of the fastest growing areas of…

Thumbnail

Orphan Drug 2022 Report

Treatments for orphan indications and rare diseases are no longer a niche area of focus for developers. Orphan products have become one of the fastest growing areas of…

Thumbnail

Orphan Drug 2022 Infographic 英語版

In 2021, over half of the FDA’s new drug approvals were for orphan or rare diseases. While orphan products are one of the fastest-growing areas of drug development, it…

Thumbnail

Orphan Drug 2022 Infographic

In 2021, over half of the FDA’s new drug approvals were for orphan or rare diseases. While orphan products are one of the fastest-growing areas of drug development, it…

Vantage logo
Independent, data-driven daily news and analysis on pharma, biotech and medtech.